The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.
Novel drug delivery system (NDDS) refers to the advance drug delivery system which improve drug potency, control drug release to give a sustained therapeutic effect, provide greater safety, finally it is to target a drug specifically to a desired tissue. It may involve scientific site targeting within the body, it is typically concerned with both quantity and duration of drug presence. The conventional dosage forms provide drug release immediately and it causes variation of drug level in blood depending upon dosage form. Therefore, to maintain the drug concentration within therapeutically effective range need NDDS. It is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
- Track 1-1Factors affecting novel drug delivery
- Track 1-2Drug delivery systems
- Track 1-3Advantages
- Track 1-4New approaches
- Track 1-5Drug carriers
- Track 1-6Potential for herbal products
- Track 1-7Future opportunities and challenges
- Track 1-8Carrier based Drug Delivery System
- Track 1-9Oral drug delivery
- Track 1-10Injection based drug delivery
Transdermal therapeutic systems are defined as self-contained, self-discrete dosage forms applied to the intact skin deliver the drug at a controlled rate to the systemic circulation. Transdermal patches include a method of delivering medication through the skin in a noninvasive manner. The patch contains the medication prescribed to the patient and they are simple to use. The classification of TDDS are: Polymer membrane permeation controlled, Polymer matrix diffusion controlled, Drug reservoir gradient controlled, Micro reservoir dissolution controlled. The equipment used for transdermal patches are For-fill seal, lamination, die-cutting, pouching whereas the manufacturing steps are blending, coating process, lamination of backing, rolling of the laminate, punching, pouching and cartooning.
- Track 2-1Basic components
- Track 2-2Evaluation
- Track 2-3Recent approaches
- Track 2-4Transdermal Delivery Methods
- Track 2-5Types of transdermal patches
- Track 2-6Components of transdermal patch
- Track 2-7Advantages and limitations
- Track 2-8Formulation
Targeted Drug Delivery system refers that the medicament is selectively targeted or delivered only to its site of action or absorption and not to the non-target organs or tissue or cells. Whereas it is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others. It is used to treat most frightful diseases like cardiac, cancers, Diabetes. It consists of a drug and carrier in passive targeting whereas in active targeting it consists of a drug, a carrier and a ligand. There are 3 basic approaches of targeting which are passive, inverse, active.
- Track 3-1Carrier or markers
- Track 3-2Types
- Track 3-3Importance in cancer therapy
- Track 3-4Therapeutic benefits
- Track 3-5Components
- Track 3-6Drug delivery vehicles
Now a days rapidly increasing variety of skin care products that are available in the market and it seems to be difficult to select one which features the best and the most effective formulation. There are different types of formulations for cosmetics which are mainly oil in water cosmetic formulation, water free cosmetic formulation, water in oil, oil free cosmetics, multiple emulsions, liposomes. Whereas these formulations are applicable for skin care products, body care solutions, hair care, face care products.
- Track 4-1Different excipients used in cosmetics
- Track 4-2Different types of APIs for different conditions
- Track 4-3Different types of active cosmetic ingredients
- Track 4-4Applications of biopolymers in food, cosmetic, medicine
- Track 4-5Different formulations used for nutraceuticals
Drug delivery systems are engineered technologies used for the targeted delivery and controlled and prolonged release of therapeutic agents. Subsequently the search for new drug delivery approaches and new modes of action is a rapidly developing field. Drug delivery systems can be advanced to target common and rare diseases. Designing of new drug delivery system has the potential to enhance the use of existing use of medicines whereas finding suitable carrier for a drug is significant to confirm it is released at the correct location within the body. The use of drug delivery may allow the drugs which were previously regarded as unsafe. The evident quick development of scientific work and strong in both experimental and clinical aspects of developments in new Drug delivery system.
- Track 5-1Development of gene based pharmaceuticals
- Track 5-2Advances in design and adaptation of gene delivery systems
- Track 5-3New carriers in drug delivery
- Track 5-4Synthesis of polymeric drug carriers
- Track 5-5Current approaches in the development of new systems
Nanotechnology has become a vital element of pharmaceutical sciences and finds multiple applications in drug delivery in enhancing therapeutic performance of drugs. Nanotechnology in drug delivery is beneficial to classify drug delivery based on time period representing before and after the nanotechnology revolution. Drug delivery approaches that control and target delivery are important to achieve clinical efficacy whereas approaches involve gold nanoparticles for targeting tumor sites and elastic capsules using Nano sized flakes. Nanotechnology is already producing new dosage forms for injectable drugs that are easier to administer for the patient. Moreover, it is also producing new opportunities in Implantable delivery systems.
- Track 6-1Nano formulations in recent clinical trails
- Track 6-2Nanotechnology based drug formulations
- Track 6-3Nanotechnology based drug delivery
- Track 6-4Nanoemulsions and Nanodispersion
Generic product is well-defined as a drug product that is comparable to branded innovator product in dosage form, strength, route of administration, quality and performance characteristics and intended use. Preformulations are classified into fundamental, derived and compatibility studies. For generic product compatibility studies are most important preformulation study. Many pre-formulation studies should be performed nevertheless generic product can be considered a duplicate of the innovator product. There is a difference in the material properties of the API and excipients used by innovator and generic manufacturer can knowingly affect performance of the dosage form. Therefore, it is important to perform preformulation studies for generic products.
- Track 7-1Quality Assurance
- Track 7-2Quality control
- Track 7-3Formulation R&D
- Track 7-4Intellectual property rights
- Track 7-5Preformulation studies
- Track 7-6Stability studies
Herbal formulation defines as a mean dosage form consisting of one or more herbs in specified quantities to provide specific nutritional, cosmetic benefits and used to treat, diagnose, mitigate diseases of human beings. Herbal drugs/herbal formulations are finished labelled products that contain active ingredients such as aerial or underground parts of plant or combinations whether in the crude state or as plant preparations. Herbal preparations are available in different forms including fresh, dried, in tablets, or capsules, or bottled in liquid form. Very rare pharmaceutical companies are involved in drug discovery screening from natural sources.
- Track 8-1Polyherbal formulation
- Track 8-2Ayurvedic formulations
- Track 8-3Quality control of crude drug materials/plant preparations/finished products
- Track 8-4Herbal formulations development for therapeutic applications
- Track 8-5Formulation and product development
- Track 8-6Methods/techniques used for formulations
A particle with at least one dimension less than 100nm is a nanoparticle. They are composed of synthetic or semisynthetic polymers carrying drugs or proteinaceous substances. Nanoparticles have developed as capable vehicles to deliver drugs in the body. Nanoparticles comprising encapsulated, dispersed, absorbed or conjugated drugs have exceptional characteristics that can lead to higher performance in a variety of dosage forms. Nanoparticles are one of the novel drug delivery systems which can be of potential use in controlling and targeting drug delivery as well as in cosmetic textiles and paints. There are recent developments in the use of nanoparticles as drug delivery systems to treat a wide variety of diseases.
- Track 9-1Nanocarriers and their applications
- Track 9-2Nanocarriers in cancer therapy
- Track 9-3Uses and advantages of nanoparticles in medicine
- Track 9-4Nanoparticles for drug delivery
Pharmaceutical products are formulated to specific dosage forms for drugs to be effectively delivered to patients. It is important to use an effective methodology whereas design of experiments and statistical analysis have been applied to formulation development and used for optimization and process validation. Formulation is the composition of a drug product that contains APIs and other inactive ingredients. In formulation the different types of are designing such as liquid, suspension, powder, solid solution, semisolid formulations. Number of technologies precisely designed to address the common problems in drug formulations.
- Track 10-1Formulation and evaluation of sustained release tablets
- Track 10-2Formulation and evaluation of Transdermal
- Track 10-3Formulation and evaluation of novel drug delivery
- Track 10-4Formulation and evaluation of Targeted drug delivery
Drug design mentioned as rational drug design is the creative process of finding new medications based on the knowledge of a biological target. New techniques are continually being developed to enhance productivity of the drug design process. In a survey of currently available market drugs 21000 registered in USA drugs and only1357 were unique. Whereas, 1204 were small molecule drugs and 166 were biological agents. In structure based drug design, it based on the knowledge of drugs three-dimensional structure and how its shape and charge cause it to interact with its biological target, ultimately elucidating a medical effect.
- Track 11-1Ligand based drug design
- Track 11-2Structure based drug design
- Track 11-3Molecular docking
- Track 11-4Protein ligand binding
- Track 11-5Rational drug design
- Track 11-6Clinical trials and development
Biopharmaceutical products are molecules that are the components of biological systems that are used in the treatment of human and animal health and disease. Formulation development of biopharmaceutical protein therapeutics. Production of biopharmaceutical involves many different, complex and lengthy steps which are synthesis, purification, formulation, final dosage preparation. Applications of biopharmaceuticals are agonist and antagonist of important receptors and enzymes, vaccines. The combination of biological molecules like antibodies with cytoxic compounds and agents, such as antibody drug used in cancer therapies.
- Track 12-1QA & QC of product
- Track 12-2Validation
- Track 12-3Methods used for drug formulation
- Track 12-4Drug formulation in pediatrics
Polymers play an important role in the DDS by providing controlled release of therapeutic agents in constant doses over long periods. Polymers have different kind of applications using in various dosage forms such as binders, suspending agents, emulsifying agents, disintegrating agents. Application of polymers in medical purpose is increasing fast and used as a main tool to control the drug release rate from the formulations and drug delivery devices.
- Track 13-1Various polymers used in drug delivery
- Track 13-2Application of polymers for formulation of dosage forms
- Track 13-3Recent advances in the use of polymers for drug delivery
- Track 13-4Preparation of polymers
- Track 13-5Biodegradable polymers
Controlled drug delivery refers to the one which delivers the drug at a predetermined rate for locally or systemically for a specified period of time. The factors influencing the release of DDS include physicochemical properties of drug, physiological factors. Controlled DDS include the maintenance of drug levels within a desired range, the need for less administrations, increased patient compliance. Controlled release drug delivery employs drug encapsulating devices from which therapeutic agents may be released at controlled rates for longer periods of time, ranging from days to months.
- Track 14-1Osmotic pressure controlled systems
- Track 14-2Chemically controlled released systems
- Track 14-3Ion exchange resin controlled
- Track 14-4Sonophoresis activated
- Track 14-5Hydrolysis activated
- Track 14-6Enzyme activated
Ocular administration of drug is primarily associated with the need to treat ophthalmic diseases. The major challenge met by todays pharmacologist and formulation scientist is ocular drug delivery. Scientists faced many challenges in Ocular drug delivery due to exceptional anatomy and physiology of eye. In ocular drug delivery there are two types of barriers which are static and dynamic barrier. The main problem in ocular drug delivery is rapid and extensive elimination of conventional eye drops from the eye. Therapeutic drug levels are not maintained for longer duration in target tissues. Moreover, various Nanoformulations have been introduced for ocular drug delivery.
- Track 15-1Types
- Track 15-2Formulation
- Track 15-3Advances
- Track 15-4Role of polymers
Children differ from adults in aspects of pharmacotherapy, capabilities of drug administration, taste preferences. It is essential that pediatric medicines are formulated to best suit a child’s age, size, condition and treatment requirements. The pediatric formulation should be with flexible dosage and minimal excipients, palatable, safe and easy to administer. Mostly conventional drug delivery systems are not acceptable for pediatric patients as they differ in their developmental status and requirements from other population. Pediatric patients require different oral drug delivery.
- Track 16-1Development of appropriate pediatric formulations
- Track 16-2Development of pediatric drug delivery
- Track 16-3Necessity of pediatric drug formulations
- Track 16-4Recent trends in pediatric drug delivery systems & formulations
Implantable drug eluting devices also referred as Implantable drug delivery system. Implantable drug delivery systems are being developed to release drugs to the bloodstream continuously as well as free patients from being hospitalized to receive IV infusions or frequent injections. They can provide localized, site specific drug delivery which is especially important in applications such as cardiology and oncology where targeted delivery can improve the effectiveness of treatment and minimize side effects.
- Track 17-1Developments
- Track 17-2Implantable drug delivery devices
- Track 17-3Recent trends in drug delivery devices
- Track 17-4Development of biodegradable drug eluting devices
- Track 17-5Therapeutic applications
The Vaccine Design and Delivery Group is an interdisciplinary and global group containing roughly 10 scientists of different foundations including drug specialists, researcher, organic chemists, physicists and biotechnologists. Since its revelation in 1796 by Edward Jenner, vaccines have been an essential part of therapeutics, opposing several infectious diseases with outstanding achievement. As of late, because of quick advances in proteomics, genomics, biotechnology and immunology and the overabundance of learning amassed in related fields, it is reasonable for vaccine development to advance at an exponential pace. Vaccines are stable, economical, require fewer doses and can be administered using needle free systems are universal significance.
- Track 18-1Design of new vaccines
- Track 18-2Role of nanoparticles
- Track 18-3Recent trends in designing
- Track 18-4Polymers in vaccine delivery
- Track 18-5Route of administration
Drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a specific route of administration. Such devices are part of one or more medical treatments. With the business sectors for biosimilars and biologics surfacing, producers have the chance to innovate and design more complex delivery methods. As competition becomes increasingly tense in both the pharmaceutical and medical devices industries, companies have moved in the direction of creating drug delivery device as a chance to differentiate themselves and to diversify their portfolio.
- Track 19-1Trends in drug delivery devices
- Track 19-2Devices used in drug delivery
- Track 19-3Challenges for manufacturers
- Track 19-4Developments
The rising demand for innovative drugs is set to initiative research within the drug delivery market, promising new formulations and more choice for consumers. Rising demand for advancements in drug delivery has encouraged major pharmaceutical companies to continue reformulating drugs and improving upon medical favorites. Moreover, self-administration and residential care and increasing demand for biosimilars and http://pulsusconference.com/genetics-molecular-biology-meetings-workshopsgeneric medicine supply vital growth prospects for player operative within the market. On the other hand, risk of needle-stick injuries and side effects of medication might restraint the expansion of the market.
- Track 20-1Advanced drug delivery systems
- Track 20-2Challenges in cancer therapy
- Track 20-3Health care trends
- Track 20-4Future challenges